Rudolf Horváth

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

Anna‐Maria Hoffmann‐Vold, Toby M. Maher, E. Philpot et al. · The Lancet Rheumatology · 2020 · 286 citations

Advanced Lung Disease, Systemic Sclerosis, Pulmonary Fibrosis +3

Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors

Daniela Rožková, Rudolf Horváth, Jiřina Bartůňková et al. · Clinical Immunology · 2006 · 160 citations

Inflammation, Toll-like Receptors, Autoimmune Disease +13

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer

Michal Podrazil, Rudolf Horváth, Étienne Becht et al. · Oncotarget · 2015 · 136 citations · Full text

Impaired Toll-like receptor 8–mediated IL-6 and TNF-α production in antigen-presenting cells from patients with X-linked agammaglobulinemia

Klára Sochorová, Rudolf Horváth, Daniela Rožková et al. · Blood · 2006 · 81 citations · Full text

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria

Marzia Palma, Lotta Hansson, Aniruddha Choudhury et al. · Cancer Immunology Immunotherapy · 2011 · 65 citations · Full text

Vaccination, Cancer Immunosurveillance, Immune Response Criteria +11